Morgan Stanley is a massive global financial services firm, with offices in 42 countries and more than 82,000 employees as of year-end 2025... Show more
Morgan Stanley holds a premier position in the financial services industry, balancing cyclical investment banking with the steadier wealth management franchise. Wealth management, now over half of revenues, benefits from scale advantages post-E*Trade integration, boasting high client retention and growing assets under management (AUM). This segment's fee-heavy model provides downside protection during volatility, with recent IRA asset growth outpacing industry averages at 15.8% CAGR since 2022. In investment banking, the firm leverages a top-tier advisory franchise and robust debt underwriting capabilities, positioning it well for market share gains as deal volumes normalize higher. Medium-term, innovation in alternatives and technology integration bolsters competitive edges, though rivals like Goldman Sachs challenge in select areas. Structural risks include talent retention and execution on expansion, but diversified revenue streams enhance resilience.
Key events loom that could sway investor views on Morgan Stanley's trajectory. The July 15, 2026, Q2 earnings release will update on equity trading—strong in Q1—and investment banking fees, amid forecasts for equity underwriting growth exceeding 20% year-over-year. An accelerating M&A and IPO pipeline, fueled by sponsor dry powder, promises fee acceleration; executives note "dramatic improvement" in deals outlook. Regulatory tailwinds include the Fed's recent stress capital buffer (SCB) reduction, freeing capital for returns or buybacks. Post-Q1, analysts raised targets en masse—Barclays to $230 (Overweight), BofA to $225 (Buy)—reflecting optimism, with upward EPS revisions dominating. These could lift sentiment if deal momentum confirms, though misses on trading volatility might temper gains.
The investment banking and wealth management sectors face a constructive yet nuanced backdrop. Moderating inflation and expected Fed rate cuts support dealmaking by easing financing costs and boosting corporate confidence, directly aiding advisory and underwriting fees. Morgan Stanley's business model ties closely to rates: higher NII from elevated levels, but cuts could spur lending while pressuring deposit spreads. Resilient U.S. consumer spending and AI-driven capex sustain wealth inflows, lessening cyclicality. Geopolitical risks and multipolar trade shifts pose headwinds, but deregulation—potentially unlocking $175 billion in excess bank capital—favors large players like MS. Technology adoption, including AI in services, offers tailwinds, aligning with the firm's strategic focus.
Tickeron’s Trend Prediction Engine is an AI-powered forecasting tool that assists traders in identifying potential bullish, bearish, or sideways movements for stocks, ETFs, and other assets over the next week or month. By analyzing vast datasets, it spots emerging trends, evaluates breakout or reversal opportunities, and provides predictions across thousands of tradable instruments. Features include searchable categories by pattern type, historical performance context, and customizable alerts for real-time notifications. This neutral, data-driven resource empowers users to make informed decisions on market trajectories.
Heading into late 2026, Morgan Stanley eyes sustained wealth management expansion, with revenue forecasts at $77.3 billion firm-wide and EPS nearing $12, buoyed by 7%+ growth into 2027. Investment banking normalization at elevated levels hinges on M&A catalysts like AI capex surges exceeding $3 trillion over three years. Cost discipline and capital allocation—dividends yielding 2.1%, buybacks—support ROTCE (return on tangible common equity) above peers. Long-term, watch margin sustainability amid rate normalization, competitive threats from fintechs, and regulatory evolution under potential deregulation. Market expansion in alternatives and global wealth channels offers upside, with consensus expectations tilting constructive on earnings trajectory.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
a provider of diversified financial services including brokerage, investment management and venture capital services
Industry InvestmentBanksBrokers
A.I.dvisor indicates that over the last year, MS has been closely correlated with GS. These tickers have moved in lockstep 83% of the time. This A.I.-generated data suggests there is a high statistical probability that if MS jumps, then GS could also see price increases.
The Stochastic Oscillator for MS moved out of overbought territory on June 09, 2026. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 65 similar instances where the indicator exited the overbought zone. In of the 65 cases the stock moved lower. This puts the odds of a downward move at .
The 10-day RSI Indicator for MS moved out of overbought territory on June 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 42 similar instances where the indicator moved out of overbought territory. In of the 42 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Moving Average Convergence Divergence Histogram (MACD) for MS turned negative on June 10, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
MS broke above its upper Bollinger Band on June 01, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MS advanced for three days, in of 353 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 312 cases where MS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. MS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.230) is normal, around the industry mean (3.991). P/E Ratio (19.388) is within average values for comparable stocks, (48.269). Projected Growth (PEG Ratio) (2.573) is also within normal values, averaging (1.823). Dividend Yield (0.019) settles around the average of (0.034) among similar stocks. P/S Ratio (4.936) is also within normal values, averaging (32.179).